Germline DNA Copy Number Aberrations Identified as Potential Prognostic Factors for Breast Cancer Recurrence
出版年份 2013 全文链接
标题
Germline DNA Copy Number Aberrations Identified as Potential Prognostic Factors for Breast Cancer Recurrence
作者
关键词
-
出版物
PLoS One
Volume 8, Issue 1, Pages e53850
出版商
Public Library of Science (PLoS)
发表日期
2013-01-17
DOI
10.1371/journal.pone.0053850
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Novel Genetic Markers of Breast Cancer Survival Identified by a Genome-Wide Association Study
- (2012) X. O. Shu et al. CANCER RESEARCH
- A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility
- (2012) Yadav Sapkota et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Genome-wide association analysis identifies three new breast cancer susceptibility loci
- (2012) Maya Ghoussaini et al. NATURE GENETICS
- The consequences of uniparental disomy and copy number neutral loss-of-heterozygosity during human development and cancer
- (2011) Pablo Lapunzina et al. BIOLOGY OF THE CELL
- Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
- (2011) Hanna Kryh et al. BMC GENOMICS
- LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability
- (2011) R. Melcher et al. CARCINOGENESIS
- Copy-Neutral Loss of Heterozygosity at the p53 Locus in Carcinogenesis of Esophageal Squamous Cell Carcinomas Associated with p53 Mutations
- (2011) H. Saeki et al. CLINICAL CANCER RESEARCH
- Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility
- (2011) Badan Sehrawat et al. HUMAN GENETICS
- Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type-3NF1deletions
- (2011) Antje M. Zickler et al. HUMAN MUTATION
- A role for XRCC2 gene polymorphisms in breast cancer risk and survival
- (2011) W.-Y. Lin et al. JOURNAL OF MEDICAL GENETICS
- Receptors, Associations, and Risk Factor Differences by Breast Cancer Subtypes: Positive or Negative?
- (2011) L. Bernstein et al. JNCI-Journal of the National Cancer Institute
- A refined molecular taxonomy of breast cancer
- (2011) M Guedj et al. ONCOGENE
- Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies
- (2010) C. O'Keefe et al. BLOOD
- Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide
- (2010) J Bray et al. BRITISH JOURNAL OF CANCER
- Functional Genetic Polymorphisms in the Aromatase Gene CYP19 Vary the Response of Breast Cancer Patients to Neoadjuvant Therapy with Aromatase Inhibitors
- (2010) L. Wang et al. CANCER RESEARCH
- Germline copy number variation and cancer risk
- (2010) Roland P Kuiper et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Germline copy number variations in BRCA1-associated ovarian cancer patients
- (2010) Kosuke Yoshihara et al. GENES CHROMOSOMES & CANCER
- Breast Cancer Subtypes and the Risk of Local and Regional Relapse
- (2010) K. David Voduc et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
- (2010) NATURE
- HIV-1/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5
- (2009) T. Nakajima et al. CYTOGENETIC AND GENOME RESEARCH
- Copy number variants, diseases and gene expression
- (2009) C. N. Henrichsen et al. HUMAN MOLECULAR GENETICS
- Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer
- (2008) Simon N Stacey et al. NATURE GENETICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started